BBC vs. UTES
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and UTES (Virtus Reaves Utilities ETF) are both exchange-traded funds - BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index, while UTES is a Utilities Equities fund actively managed by Virtus. BBC is passively managed, while UTES is actively managed. Over the past 10 years, BBC returned 9.38%/yr vs 12.14%/yr for UTES. Their 0.15 correlation means their historical movements had little consistent relationship. BBC charges 0.79%/yr vs 0.49%/yr for UTES.
Performance
BBC vs. UTES - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 27.03% return, which is significantly higher than UTES's 0.36% return. Over the past 10 years, BBC has underperformed UTES with an annualized return of 9.38%, while UTES has yielded a comparatively higher 12.14% annualized return.
BBC
- 1D
- 0.50%
- 1M
- -7.22%
- 6M
- 16.85%
- YTD
- 27.03%
- 1Y
- 132.20%
- 3Y*
- 29.78%
- 5Y*
- 2.55%
- 10Y*
- 9.38%
- ALL TIME*
- 6.30%
UTES
- 1D
- 1.44%
- 1M
- -2.90%
- 6M
- 3.82%
- YTD
- 0.36%
- 1Y
- -2.59%
- 3Y*
- 22.82%
- 5Y*
- 14.89%
- 10Y*
- 12.14%
- ALL TIME*
- 13.64%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $614.18K | $1.46M | $1.24M | |
| $11.31M | $10.12M | $13.80M |
BBC vs. UTES - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 27.03% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
UTES Virtus Reaves Utilities ETF | 0.36% | 25.71% | 45.35% | -2.46% | 0.80% | 20.74% | -0.30% | 25.48% | 5.14% | 14.21% |
Correlation
The correlation between BBC and UTES is 0.21, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.21 |
Correlation (3Y) Balances recent behavior with more history. | 0.26 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.25 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.18 |
Correlation (All Time) Calculated using the full available price history since Sep 24, 2015 | 0.15 |
The correlation between BBC and UTES shifts across timeframes, from 0.15 (all time) to 0.26 (3 years), reflecting how their relationship changes across market environments.
BBC vs. UTES - Sectors Allocation Comparison
Sectors
BBC
UTES
Healthcare
-
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
Healthcare
BBC
UTES
-
Financial Services
BBC
UTES
-
Basic Materials
BBC
-
UTES
-
Communication Services
BBC
-
UTES
-
Consumer Cyclical
BBC
-
UTES
-
Consumer Defensive
BBC
-
UTES
-
Energy
BBC
-
UTES
-
Industrials
BBC
-
UTES
-
Real Estate
BBC
-
UTES
-
Technology
BBC
-
UTES
-
Utilities
BBC
-
UTES
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. UTES — Risk / Return Rank
BBC
UTES
BBC vs. UTES - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Virtus Reaves Utilities ETF (UTES). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBC | UTES | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.77 | ||
| Sortino ratioReturn per unit of downside risk | +4.10 | ||
| Omega ratioGain probability vs. loss probability | 1.48 | 1.00 | +0.49 |
| Calmar ratioReturn relative to maximum drawdown | 8.81 | -0.19 | +8.99 |
| Martin ratioReturn relative to average drawdown | 23.93 | -0.39 | +24.31 |
Loading charts...
Drawdowns
BBC vs. UTES - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, which is greater than UTES's maximum drawdown of -35.39%. Use the drawdown chart below to compare losses from any high point for BBC and UTES.
Loading charts...
Drawdown Indicators
| BBC | UTES | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -35.39% | -41.46% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -13.88% | -1.22% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -17.62% | -36.83% |
Max Drawdown (5Y)Largest decline over 5 years | -70.92% | -20.40% | -50.52% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | -35.39% | -41.46% |
Current DrawdownCurrent decline from peak | -18.46% | -9.00% | -9.46% |
Average DrawdownAverage peak-to-trough decline | -36.87% | -5.54% | -31.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.55% | 6.74% | -1.19% |
Volatility
BBC vs. UTES - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 10.19% compared to Virtus Reaves Utilities ETF (UTES) at 5.50%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than UTES based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBC | UTES | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.19% | 5.50% | +4.69% |
Volatility (6M)Calculated over the trailing 6-month period | 26.25% | 16.23% | +10.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.52% | 21.46% | +15.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.61% | 20.75% | +18.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.72% | 20.27% | +17.45% |
BBC vs. UTES - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than UTES's 0.49% expense ratio.
Dividends
BBC vs. UTES - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.34%, less than UTES's 1.51% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.34% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
UTES Virtus Reaves Utilities ETF | 1.51% | 1.42% | 1.51% | 2.44% | 2.13% | 1.94% | 2.09% | 1.84% | 2.09% | 3.44% | 3.53% | 0.61% |
Frequently Asked Questions
BBC and UTES have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (10.19%) compared to UTES (5.50%). In terms of maximum drawdown, BBC dropped -76.85% vs UTES's -35.39%.
On 10-year performance, UTES leads with 12.14% vs 9.38% for BBC. On fees, UTES is cheaper at 0.49% per year. On volatility, UTES has been the lower-risk option at 5.50%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, UTES has performed better with a 12.14% return vs 9.38%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
UTES is cheaper with a 0.49% expense ratio, compared with 0.79% for BBC.
UTES has the higher dividend yield at 1.51%, compared with 1.34% for BBC.
BBC is categorized as Health & Biotech Equities, while UTES is Utilities Equities. Their fees differ too: 0.79% for BBC and 0.49% for UTES.
BBC currently has the higher Sharpe Ratio (3.65 vs -0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBC and UTES
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer